Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Armata Pharmaceuticals, Inc. has filed 1,156 SEC EDGAR filings since 06 Feb 1996

SEC filing history

Showing 151-175 of 181 matching filings.

Per page
25
Current page
7
8-K File 001-37544

8-K

Filing date
18 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
10 Nov 2015
Reporting date
05 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

8-K

Filing date
24 Sep 2015
Reporting date
21 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

8-K

Filing date
10 Sep 2015
Reporting date
03 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
04 Aug 2015
Reporting date
19 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
04 Aug 2015
Reporting date
04 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
22 May 2015
Reporting date
19 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
15 May 2015
Reporting date
08 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
01 May 2015
Reporting date
28 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
23 Apr 2015
Reporting date
16 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
19 Mar 2015
Reporting date
16 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
12 Mar 2015
Reporting date
10 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
09 Mar 2015
Reporting date
03 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
23 Jan 2015
Reporting date
20 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

FORM 8-K

Filing date
14 Jan 2015
Reporting date
11 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
09 Jan 2015
Reporting date
06 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
24 Dec 2014
Reporting date
19 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
06 Nov 2014
Reporting date
31 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
31 Oct 2014
Reporting date
27 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
17 Oct 2014
Reporting date
13 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
19 Sep 2014
Reporting date
15 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
21 Aug 2014
Reporting date
18 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
02 Jul 2014
Reporting date
27 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

FORM 8-K

Filing date
22 May 2014
Reporting date
19 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23930

8-K

Filing date
20 May 2014
Reporting date
15 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .